(IBHI) iShares iBonds 2029 Term - Ratings and Ratios
High-Yield Bonds, BBB-Rated Bonds, 2029 Maturity, Corporate Bonds
Dividends
| Dividend Yield | 6.24% |
| Yield on Cost 5y | 7.61% |
| Yield CAGR 5y | 8.92% |
| Payout Consistency | 98.9% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 3.40% |
| Value at Risk 5%th | 5.71% |
| Relative Tail Risk | 1.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.59 |
| Alpha | 0.34 |
| CAGR/Max DD | 1.58 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.208 |
| Beta | 0.244 |
| Beta Downside | 0.293 |
| Drawdowns 3y | |
|---|---|
| Max DD | 5.73% |
| Mean DD | 0.89% |
| Median DD | 0.48% |
Description: IBHI iShares iBonds 2029 Term January 02, 2026
The iShares iBonds 2029 Term High Yield and Income ETF (BATS: IBHI) tracks an index of U.S.-dollar-denominated, taxable, fixed-rate corporate bonds rated BBB or lower that all mature between January 1 and December 15 2029. To fully replicate the index, the fund may hold non-U.S. issuers, and it is classified as a non-diversified, target-maturity ETF.
Key fund attributes: ticker IBHI; ETF type; U.S. domicile; falls under the “Target Maturity” category, which means its portfolio will wind down as the 2029 maturity date approaches, reducing duration risk over time.
Additional context (as of early 2026): the ETF’s weighted-average yield sits near 6.2 % (≈ 5-year high-yield average), its effective duration is roughly 4.5 years, and the spread to Treasuries has narrowed to about 350 basis points, reflecting a tightening high-yield market amid a still-moderate economic slowdown. Credit-cycle sensitivity and the Federal Reserve’s policy path remain the primary drivers of performance.
For a deeper dive into how IBHI’s risk-return profile stacks up against comparable high-yield strategies, you might explore the analytics on ValueRay.
What is the price of IBHI shares?
Over the past week, the price has changed by -0.04%, over one month by +0.58%, over three months by +1.05% and over the past year by +7.56%.
Is IBHI a buy, sell or hold?
What are the forecasts/targets for the IBHI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 26.8 | 13.3% |
IBHI Fundamental Data Overview January 01, 2026
Beta = 0.79
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 337.9m USD (337.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 337.9m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 337.9m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.92% (E(337.9m)/V(337.9m) * Re(6.92%) + (debt-free company))
Discount Rate = 6.92% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBHI ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle